Cognition Therapeutics (CGTX) Capital Expenditures (2022 - 2024)
Cognition Therapeutics (CGTX) reported Capital Expenditures of $1000.0 for Q4 2024, down 96.67% year-over-year from $30000.0 in Q1 2024, and down 96.67% on a QoQ basis from $30000.0 in Q4 2023.
Cognition Therapeutics (CGTX) has 3 years of Capital Expenditures data on file, last reported at $1000.0 in Q4 2024.
- Quarterly Capital Expenditures fell 96.67% year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $89000.0 (down 39.46% YoY) and the FY2024 annual result came in at $4000.0, down 97.28% from the prior year.
- Capital Expenditures fell to $1000.0 in Q4 2024 per CGTX's latest filing, from $30000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $134000.0 in Q1 2022 and bottomed at $1000.0 in Q4 2024.
- The 3-year median for Capital Expenditures is $23000.0 (2022), against an average of $35444.4.
- The widest annual swing landed in 2023, when Capital Expenditures surged 350.0%; it then sank 96.67% in 2024.
- Tracing CGTX's Capital Expenditures over 3 years: stood at $10000.0 in 2022, then surged by 200.0% to $30000.0 in 2023, then tumbled by 96.67% to $1000.0 in 2024.
- Per Business Quant, the three latest CGTX Capital Expenditures figures stand at $1000.0 (Q4 2024), $30000.0 (Q4 2023), and $58000.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 230.60 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Mar 31, 2022 | 134,000.00 |